Literature DB >> 11276560

Combination treatment effective option for hypertensive, diabetic patients with microalbuminuria.

B H Chen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11276560      PMCID： PMC80906     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  2 in total

1.  1999 Canadian recommendations for the management of hypertension. Task Force for the Development of the 1999 Canadian Recommendations for the Management of Hypertension.

Authors:  R D Feldman; N Campbell; P Larochelle; P Bolli; E D Burgess; S G Carruthers; J S Floras; R B Haynes; G Honos; F H Leenen; L A Leiter; A G Logan; M G Myers; J D Spence; K B Zarnke
Journal:  CMAJ       Date:  1999       Impact factor: 8.262

2.  Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.

Authors:  L M Ruilope; J C Aldigier; C Ponticelli; P Oddou-Stock; F Botteri; J F Mann
Journal:  J Hypertens       Date:  2000-01       Impact factor: 4.844
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.